366 related articles for article (PubMed ID: 28797204)
41. C-reactive Protein (CRP) as a Single Biomarker for Diagnosis of Neonatal Sepsis: A Comprehensive Meta-analysis.
Shabuj KH; Hossain J; Moni SC; Dey SK
Mymensingh Med J; 2017 Apr; 26(2):364-371. PubMed ID: 28588174
[TBL] [Abstract][Full Text] [Related]
42. Serum amyloid A - A prime candidate for identification of neonatal sepsis.
Bengnér J; Quttineh M; Gäddlin PO; Salomonsson K; Faresjö M
Clin Immunol; 2021 Aug; 229():108787. PubMed ID: 34175457
[TBL] [Abstract][Full Text] [Related]
43. [Evaluation of C reactive protein and others immunologic markers in the diagnosis of neonatal sepsis].
Zuppa AA; Calabrese V; D'Andrea V; Fracchiolla A; Scorrano A; Orchi C; Romagnoli C
Minerva Pediatr; 2007 Jun; 59(3):267-74. PubMed ID: 17519872
[TBL] [Abstract][Full Text] [Related]
44. Utility of interleukin-12 and interleukin-10 in comparison with other cytokines and acute-phase reactants in the diagnosis of neonatal sepsis.
Sherwin C; Broadbent R; Young S; Worth J; McCaffrey F; Medlicott NJ; Reith D
Am J Perinatol; 2008 Nov; 25(10):629-36. PubMed ID: 18850512
[TBL] [Abstract][Full Text] [Related]
45. Presepsin as a predictor of positive blood culture in suspected neonatal sepsis.
Miyosawa Y; Akazawa Y; Kamiya M; Nakamura C; Takeuchi Y; Kusakari M; Nakamura T
Pediatr Int; 2018 Feb; 60(2):157-161. PubMed ID: 29205640
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of the S100 protein A12 as a biomarker of neonatal sepsis.
Tosson AMS; Glaser K; Weinhage T; Foell D; Aboualam MS; Edris AA; El Ansary M; Lotfy S; Speer CP
J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2768-2774. PubMed ID: 30563403
[No Abstract] [Full Text] [Related]
47. Rapid detection of bacteria in bloodstream infections using a molecular method: a pilot study with a neonatal diagnostic kit.
Mazzucchelli I; Garofoli F; Angelini M; Tinelli C; Tzialla C; Decembrino L
Mol Biol Rep; 2020 Jan; 47(1):363-368. PubMed ID: 31642041
[TBL] [Abstract][Full Text] [Related]
48. Early and late markers for the detection of early-onset neonatal sepsis.
Bender L; Thaarup J; Varming K; Krarup H; Ellermann-Eriksen S; Ebbesen F
Dan Med Bull; 2008 Nov; 55(4):219-23. PubMed ID: 19232162
[TBL] [Abstract][Full Text] [Related]
49. Serum Level of Antithrombin III (ATIII) Could Serve as a Prognostic Biomarker in Neonatal Sepsis.
Samra N; AlGhwass M; Elgawhary S; Hassan M; Bekhit O; Mohamed W; Eid M
Fetal Pediatr Pathol; 2019 Aug; 38(4):290-298. PubMed ID: 30931675
[No Abstract] [Full Text] [Related]
50. Evaluation of a turbidimetric C-reactive protein assay to monitor early-onset neonatal sepsis in South Kivu (Democratic Republic of the Congo).
Mulinganya G; Balolebwami S; Zigabe S; Mongane J; Nianci I; Burume A; Hendwa E; Kampara F; Maheshe G; Sadiki Kishabongo A; Bisimwa G; Cools P; Speeckaert M; Callens S; Delanghe J
Clin Chem Lab Med; 2021 Feb; 59(3):625-630. PubMed ID: 32374279
[TBL] [Abstract][Full Text] [Related]
51. Endocan serum concentration in uninfected newborn infants.
Zonda GI; Zonda R; Cernomaz AT; Paduraru L; Grigoriu BD
J Infect Dev Ctries; 2019 Sep; 13(9):817-822. PubMed ID: 32074091
[TBL] [Abstract][Full Text] [Related]
52. C-reactive Protein as a Screening Biomarker in Neonatal Sepsis.
Khan F
J Coll Physicians Surg Pak; 2019 Oct; 29(10):951-953. PubMed ID: 31564268
[TBL] [Abstract][Full Text] [Related]
53. [Clinical criteria for pathogen bacteria in term newborn suspected of neonatal sepsis].
Glusko-Charlet A; Fontaine C; Raucy M; Barcat L; Lahana A; Erbani R; Poirie G; Kongolo G; Diouf M; Leke A; Gondry J; Tourneux P
Arch Pediatr; 2017 Oct; 24(10):934-941. PubMed ID: 28893488
[TBL] [Abstract][Full Text] [Related]
54. Comparative Assessment of Cytokine Pattern in Early and Late Onset of Neonatal Sepsis.
Khaertynov KS; Boichuk SV; Khaiboullina SF; Anokhin VA; Andreeva AA; Lombardi VC; Satrutdinov MA; Agafonova EA; Rizvanov AA
J Immunol Res; 2017; 2017():8601063. PubMed ID: 28367457
[TBL] [Abstract][Full Text] [Related]
55. Evaluating Newborns at Risk for Early-Onset Sepsis.
Good PI; Hooven TA
Pediatr Clin North Am; 2019 Apr; 66(2):321-331. PubMed ID: 30819339
[TBL] [Abstract][Full Text] [Related]
56. Copper and selenium status as biomarkers of neonatal infections.
Hackler J; Wisniewska M; Greifenstein-Wiehe L; Minich WB; Cremer M; Bührer C; Schomburg L
J Trace Elem Med Biol; 2020 Mar; 58():126437. PubMed ID: 31778962
[TBL] [Abstract][Full Text] [Related]
57. Implementation of the Neonatal Sepsis Calculator in an Australian Tertiary Perinatal Centre.
Strunk T; Buchiboyina A; Sharp M; Nathan E; Doherty D; Patole S
Neonatology; 2018; 113(4):379-382. PubMed ID: 29514161
[TBL] [Abstract][Full Text] [Related]
58. Advancement in biomarker based effective diagnosis of neonatal sepsis.
Gopal N; Chauhan N; Jain U; Dass SK; Sharma HS; Chandra R
Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):476-490. PubMed ID: 37656048
[TBL] [Abstract][Full Text] [Related]
59. Biomarkers as point of care tests (POCT) in neonatal sepsis: A state of science review.
Taneja R; Batra P
J Neonatal Perinatal Med; 2021; 14(3):331-338. PubMed ID: 33337395
[TBL] [Abstract][Full Text] [Related]
60. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills?
Sridharan P; Chamberlain RS
Surg Infect (Larchmt); 2013 Dec; 14(6):489-511. PubMed ID: 24274059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
